![Andy Crew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Andy Crew worked as a Senior Director at OSI Pharmaceuticals and Astellas Pharmaceuticals SA from 2002 to 2013.
He was also a Principal Scientist at Knoll Pharmaceutical Co. from 1990 to 1996.
Later, he worked as a Senior Vice President-Chemistry at Arvinas Operations, Inc. and Arvinas, Inc. from an unknown date to 2019.
Dr. Crew holds a doctorate degree from The University of Liverpool.
Anciens postes connus de Andy Crew
| Sociétés | Poste | Fin |
|---|---|---|
| OSI PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2013 |
Astellas Pharmaceuticals SA | Directeur/Membre du Conseil | 01/01/2013 |
Knoll Pharmaceutical Co. | Corporate Officer/Principal | 01/01/1996 |
| ARVINAS, INC. | Directeur Technique/Scientifique/R&D | - |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Corporate Officer/Principal | - |
Formation de Andy Crew
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Knoll Pharmaceutical Co. | |
Astellas Pharmaceuticals SA | |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
